Surgical management of Metacarpal brown tumor. A case report
DOI:
https://doi.org/10.1016/j.rccot.2020.04.014Keywords:
brown tumour, surgical management, non-vascularised fibula, bone graftAbstract
The brown tumour, also known as osteoclastoma, or as osteitis fibrosa cystica, is a lytic tumour, which occurs in hyperparathyroidism (primary, secondary, and tertiary), although its usual presentation is highly invasive, has no potential for malignancy. Brown tumours of the hand are sporadic, and there are only few case reports. The case is presented of an 18-year-old male patient with a solid, non-mobile tumour, adhered to deep planes, in the dorsal region of the right hand over the fourth metacarpal. This also limited the flexion and extension of the fourth finger, but did not show alterations in the neurovascular function of the finger. The patient underwent a tumour resection that completely involved the right fourth metacarpal. A direct lateral approach was made in the left pelvic limb to perform a non-vascularised autologous fibular graft. Early detection of this type of tumour is important, and an adequate follow-up must be carried out, since when they progress, they generate significant bone destruction and the treatment becomes more complex. In early stages, aggressive management of resection and bone support can prevent functional sequelae.
Downloads
References
Bahrami E, Alireza T, Ebrahim H, Mohammadreza S. Maxillary and orbital brown tumor of primary hyperparathyroidism. The American journal of case reports. 2012;13:183. https://doi.org/10.12659/AJCR.883325
Damjanov I, Linder J. Anderson's Pathology-Vol 1. 10th ed. Ayala AG RJ, Raymond AK, editor: Mosby; 1996.
Griffiths HJ, Ennis JT, Bailey G. Skeletal changes following renal transplantation. Radiology. 1974;113:621-6. https://doi.org/10.1148/113.3.621
Irie T, Mawatari T, Ikemura S, Matsui G, Iguchi T, Mitsuyasu H. Brown tumor of the patella caused by primary hyperparathyroidism: a case report. Korean journal of radiology. 2015;16: 613-6. https://doi.org/10.3348/kjr.2015.16.3.613
Massry SG, Ritz E. The pathogenesis of secondary hyperparathyroidism of renal failure: Is there a controversy? Archives of internal medicine. 1978;138 Suppl 5:853-6. https://doi.org/10.1001/archinte.138.Suppl_5.853
Pérez-Guillermo M, Acosta-Ortega J, García-Solano J, RamosFreixá J. Cytologic aspect of brown tumor of hyperparathyroidism Report of a case affecting the hard palate. Diagnostic cytopathology. 2006;34:291-4. https://doi.org/10.1002/dc.20434
Etemadi J, Mortazavi-Khosrowshahi M, Ardalan M, Esmaili H, Javadrashid R, Shoja M. editors. Brown tumor of hyperparathyroidism masquerading as central giant cell granuloma in a renal transplant recipient: a case report. Transplantation proceedings;. 2009. Elsevier. https://doi.org/10.1016/j.transproceed.2009.07.040
Nassar GM, Ayus JC. Brown tumor in end-stage renal disease. The New England Journal of Medicine. 1999;341:1652. https://doi.org/10.1056/NEJM199911253412204
Resic H, Masnic F, Kukavica N, Spasovski G. Unusual clinical presentation of brown tumor in hemodialysis patients: two case reports. International urology and nephrology. 2011;43:575-80. https://doi.org/10.1007/s11255-010-9738-3
Feldman F. Primary bone tumors of the hand and carpus. Hand clinics. 1987;3:269-89. https://doi.org/10.1016/S0749-0712(21)00658-2
Rossi B, Ferraresi V, Appetecchia M, Novello M, Zoccali C. Giant cell tumor of bone in a patient with diagnosis of primary hyperparathyroidism: a challenge in differential diagnosis with brown tumor. Skeletal Radiology. 2014;43(5.). https://doi.org/10.1007/s00256-013-1770-9
Su AW, Chen C-F, Huang C-K, Chen PC-H, Chen W-M, Chen TH. Primary hyperparathyroidism with brown tumor mimicking metastatic bone malignancy. Journal of the Chinese Medical Association. 2010;73:177-80. https://doi.org/10.1016/S1726-4901(10)70035-6
Germann G, Wind G, Harth A. The DASH (Disability of ArmShoulder-Hand) Questionnaire-a new instrument for evaluating upper extremity treatment outcome. Handchirurgie, Mikrochirurgie, plastische Chirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse: Organ der V. 1999;31:149-52.
Al-Sharafi BA, Al-Imad SA, Shamshair AM, Al-Faqeeh DH. Brown tumours of the tibia and second metacarpal bone in a woman with severe vitamin D deficiency. BMJ case reports. 2015, bcr2014207722. https://doi.org/10.1136/bcr-2014-207722
Altay C, Erdo˘gan N, Eren E, Altay S, Karasu ¸,S Uluc¸ E. Computed tomography findings of an unusual maxillary sinus mass: brown tumor due to tertiary hyperparathyroidism. Journal of clinical imaging science. 2013:3. https://doi.org/10.4103/2156-7514.122325
Hussain M, Hammam M. Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report. Journal of medical case reports. 2016;10:166. https://doi.org/10.1186/s13256-016-0933-4
Fan Y, Hanai J-i, Le PT, Bi R, Maridas D, DeMambro V, et al. Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell metabolism. 2017;25:661-72. https://doi.org/10.1016/j.cmet.2017.01.001
Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Current opinion in pharmacology. 2015;22:41-50. https://doi.org/10.1016/j.coph.2015.03.005
Campbell EJ, Campbell GM, Hanley DA. The effect of parathyroid hormone and teriparatide on fracture healing. Expert opinion on biological therapy. 2015;15:119-29. https://doi.org/10.1517/14712598.2015.977249
Kong J, Qiao G, Zhang Z, Liu SQ, Li YC. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney international. 2008;74:1577-81. https://doi.org/10.1038/ki.2008.452
Stanbury S. The role of vitamin D in renal bone disease. Clinical endocrinology. 1977;7(s1.). https://doi.org/10.1111/j.1365-2265.1977.tb03358.x
Erturk E, Keskin M, Ersoy C, Kaleli T, Imamoglu S, Filiz G. Metacarpal brown tumor in secondary hyperparathyroidism due to vitamin-D deficiency: a case report. JBJS. 2005;87:1363-6. https://doi.org/10.2106/00004623-200506000-00026
Tarrass F, Ayad A, Benjelloun M, Anabi A, Ramdani B, Benghanem MG, et al. Cauda equina compression revealing brown tumor of the spine in a long-term hemodialysis patient. Joint Bone Spine. 2006;73:748-50. https://doi.org/10.1016/j.jbspin.2006.01.011
Pavlovic S, Valyi-Nagy T, Profirovic J, David O. Fine-needle aspiration of brown tumor of bone: Cytologic features with radiologic and histologic correlation. Diagnostic cytopathology. 2009;37:136-9. https://doi.org/10.1002/dc.20974
Verma P, Verma KG, Verma D, Patwardhan N. Craniofacial brown tumor as a result of secondary hyperparathyroidism in chronic renal disease patient: A rare entity. Journal of oral and maxillofacial pathology: JOMFP. 2014;18:267. https://doi.org/10.4103/0973-029X.140779
Gedik G, Ata O, Karabagli P, Sari O. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m) Tc-MDP,(18) F-FDG PET/CT and (99m) Tc-MIBI scans. Hellenic journal of nuclear medicine. 2014;17:214.
Yadav J, Madaan P, Jain V. Brown tumor due to vitamin D deficiency in a child with cerebral palsy. The Indian Journal of Pediatrics. 2014;81:1419-20. https://doi.org/10.1007/s12098-014-1517-1
Salem K, Brown CO, Schibler J, Goel A. Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-B activity. Exp Hematol. 2013:41. https://doi.org/10.1016/j.exphem.2012.10.002
Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nature Reviews Nephrology. 2013;9:459-69. https://doi.org/10.1038/nrneph.2013.110
Pechalova PF, Poriazova EG. Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure. Acta Medica (Hradec Kralove). 2013;56:83-6. https://doi.org/10.14712/18059694.2014.29
Artul S, Bowirrat A, Yassin M, Armaly Z. Maxillary and frontal bone simultaneously involved in brown tumor due to secondary hyperparathyroidism in a hemodialysis patient. Case reports in oncological medicine. 2013:2013. https://doi.org/10.1155/2013/909150
Mantar F, Gunduz S, Gunduz U. A reference finding rarely seen in primary hyperparathyroidism: brown tumor. Case reports in medicine. 2012:2012. https://doi.org/10.1155/2012/432676
Fish R, Danneman PJ, Brown M, Karas A. Anesthesia and analgesia in laboratory animals:. Academic Press; 2011.
Mateo L, Massuet A, Solà M, Andrés RP, Musulen E, Torres MCS. Brown tumor of the cervical spine: a case report and review of the literature. Clinical rheumatology. 2011;30:419-24. https://doi.org/10.1007/s10067-010-1608-y
Meng Z, Zhu M, He Q, Tian W, Zhang Y, Jia Q, et al. Clinical implications of brown tumor uptake in whole-body 99mTcsestamibi scans for primary hyperparathyroidism. Nuclear medicine communications. 2011;32:708-15. https://doi.org/10.1097/MNM.0b013e328347b582
Hong WS, Sung MS, Chun K-A, Kim J-Y, Park S-W, Lee K-H, et al. Emphasis on the MR imaging findings of brown tumor: a report of five cases. Skeletal radiology. 2011;40:205-13. https://doi.org/10.1007/s00256-010-0979-0
Jakubowski JM, Velez I, McClure SA. Brown tumor as a result of hyperparathyroidism in an end-stage renal disease patient. Case reports in radiology. 2011;2011:2011, 415476. doi: 10.1155/2011/415476. https://doi.org/10.1155/2011/415476
Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell metabolism. 2010;12:662-7. https://doi.org/10.1016/j.cmet.2010.11.015
Brown NJ. Aldosterone and vascular inflammation. Hypertension. 2008;51:161-7. https://doi.org/10.1161/HYPERTENSIONAHA.107.095489
Treglia G, Dambra DP, Bruno I, Mulè A, Giordano A. Costal brown tumor detected by dual-phase parathyroid imaging and SPECTCT in primary hyperparathyroidism. Clinical nuclear medicine. 2008;33:193-5. https://doi.org/10.1097/RLU.0b013e318162dd89
Khalil P, Heining S, Huss R, Ihrler S, Siebeck M, Hallfeldt K, et al. Natural history and surgical treatment of brown tumor lesions at various sites in refractory primary hyperparathyroidism. European journal of medical research. 2007;12:222.
Cebesoy O, Karakok M, Arpacioglu O, Baltaci E. Brown tumor with atypical localization in a normocalcemic patient. Archives of Orthopaedic & Trauma Surgery. 2007;127:577-80. https://doi.org/10.1007/s00402-007-0302-2
Diamanti-Kandarakis E, Livadas S, Tseleni-Balafouta S, Lyberopoulos K, Tantalaki E, Palioura H, et al. Brown tumor of the fibula: unusual presentation of an uncommon manifestation Report of a case and review of the literature. Endocrine. 2007;32:345-9. https://doi.org/10.1007/s12020-008-9035-4
Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension. 2006;48:51-7. https://doi.org/10.1161/01.HYP.0000225402.69580.1d
Takeshita T, Takeshita K, Abe S, Takami H, Imamura T, Furui S. Brown tumor with fluid-fluid levels in a patient with primary hyperparathyroidism: radiological findings. Radiation medicine. 2006;24:631-4. https://doi.org/10.1007/s11604-006-0068-4
Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. The Journal of physiology. 2005;564:619-30. https://doi.org/10.1113/jphysiol.2004.081323
Brown NJ. Aldosterone and end-organ damage. Current opinion in nephrology and hypertension. 2005;14:235-41. https://doi.org/10.1097/01.mnh.0000165889.60254.98
Fernandez J, Anton I, Costas A. Brown tumor of the mandible as first manifestation of primary hyperparathyroidism: diagnosis and treatment. Medicina oral, patología oral y cirugía bucal. 2005;10:169-72.
Dursun H, Küc¸ükosmanoglu O, Noyan A, Özbarlas N, Büyükc¸elik M, Soran M, et al. Mitral annular calcification and brown tumor of the rib in a child with chronic renal failure. Pediatric Nephrology. 2005;20:673-5. https://doi.org/10.1007/s00467-004-1721-8
Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, et al. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell. 1993;72:729-39. https://doi.org/10.1016/0092-8674(93)90401-B
Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, Kanno T, et al. The oncoprotein Bcl-3 can facilitate NFkappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J. 1993;12: 3893-901. https://doi.org/10.1002/j.1460-2075.1993.tb06067.x
Chew F, Huang-Hellinger F. Brown tumor. AJR American journal of roentgenology. 1993;160:752. https://doi.org/10.2214/ajr.160.4.8456657
